Lupus

Increasing clinical trial awareness and support among Black patients with lupus, with the cooperation of nurses, will require improving trust and strong relationships, noted a speaker at the 2023 ACR Clinical Trials Summit.

Despite the fact that Black individuals routinely demonstrate the highest prevalence rates for lupus — with frequencies two to three times that of white individuals — they still account for just 14% of clinical trial participants.

Although testing for antinuclear antibodies is widely viewed as an effective screening tool for lupus and other autoimmune diseases, many rheumatologists fear that excessive ANA testing does more harm than good.

Healio spoke with I. Paul Singh, MD, about risk factors for developing dry eye, particularly in women.

Patients with childhood systemic lupus erythematosus who receive care that closely adheres to quality metrics demonstrate better outcomes, according to data published in Arthritis Care & Research.

Steroid sparing with novel agents, including belimumab and voclosporin, is recommended for patients with systemic lupus erythematosus, according to updated guidelines presented at the EULAR 2023 Congress.

Treating patients with lupus can be likened to fighting a war, in which victory is achieved not through a single promising therapy, but winning many smaller battles, according to a speaker at EULAR 2023 Congress.

The FDA has granted fast-track designation to Kyverna’s KYV-101, a novel anti-CD19 chimeric antigen receptor T-cell therapy for patients with refractory lupus nephritis, according to a company press release.

Family income level is a significant predictor of longer hospital stays among children with lupus in the lowest income quartile, according to data published in Arthritis Care & Research.

The Lupus Research Alliance, alongside its research affiliate Lupus Therapeutics, have announced the launch of what would be the largest prospective observational study into lupus, as well as a new patient registry and data resource.